Concepedia

Publication | Open Access

Dipeptidyl Peptidase-4 Inhibition in Patients with Type 2 Diabetes Treated with Saxagliptin, Sitagliptin, or Vildagliptin

DOIFull Paper Access

47

Citations

16

References

2013

Year

Daniel Tatosian, Ying Guo, Andrea Schaeffer, Natalia Gaibu, Serghei Popa, Aubrey Stoch, Ronald B. Langdon, Eunkyung Kauh
Diabetes Therapy

Abstract

Once daily treatment with sitagliptin provided trough DPP-4 inhibition significantly greater than saxagliptin or vildagliptin administered once daily, and similar to that provided by vildagliptin administered twice daily.

References

YearCitations

Page 1